Clarius Group LLC’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Clarius Group LLC’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20,000	Closed	-$4.99K	–	477
2024 Q2	$4.99K	Hold	20,000	–	–	﹤0.01%	447
2024 Q1	$14.3K	Hold	20,000	–	–	﹤0.01%	484
2023 Q4	$17K	Hold	20,000	–	–	﹤0.01%	477
2023 Q3	$27.4K	Buy	+20,000	New	+$43.3K	﹤0.01%	460
2023 Q2	–	Sell	-20,000	Closed	-$45.4K	–	526
2023 Q1	$45.4K	Hold	20,000	–	–	﹤0.01%	503
2022 Q4	$28K	Hold	20,000	–	–	﹤0.01%	511
2022 Q3	$40K	Hold	20,000	–	–	﹤0.01%	487
2022 Q2	$31K	Buy	+20,000	New	+$75.6K	﹤0.01%	466

Clarius Group LLC's VAXX Position: Q3 2024 in Review

Clarius Group LLC sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q3 2024, closing a stake of 20,000 shares — an estimated $4.99K sold.

Clarius Group LLC first reported a position in VAXX in Q2 2022 and held it in 8 quarters. The position peaked at $45.4K in Q1 2023. 0 funds tracked by Wall St. Rank hold VAXX as of Q3 2024.

Clarius Group LLC reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q3 2024 after selling out during the quarter.
Clarius Group LLC sold 20,000 Vaxxinity, Inc. Class A Common Stock shares in Q3 2024, an estimated $4.99K.
Clarius Group LLC first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2022 and held it in 8 quarters.
Clarius Group LLC's Vaxxinity, Inc. Class A Common Stock position peaked at $45.4K in Q1 2023.
0 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q3 2024.

Based on Clarius Group LLC's 13F filing for Q3 2024, filed 9 Oct 2024.